[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]

October 2018 - April 2016

Decade

Year

Issue

October 2018, Vol 3, No. 10, Pages 903-1026

In This Issue of JAMA Cardiology

Highlights

Abstract Full Text
free access
JAMA Cardiol. 2018;3(10):903. doi:10.1001/jamacardio.2017.3386
Original Investigation

Trends in Hospice Discharge and Relative Outcomes Among Medicare Patients in the Get With The Guidelines–Heart Failure Registry

Abstract Full Text
JAMA Cardiol. 2018;3(10):917-926. doi:10.1001/jamacardio.2018.2678

This cohort analysis of Medicare beneficiaries in the American Heart Association Get With The Guidelines–Heart Failure registry assesses rates of discharge to hospice, readmission after hospice, and survival in hospice in patients following hospital discharge.

Association of Variants in BAG3 With Cardiomyopathy Outcomes in African American Individuals

Abstract Full Text
JAMA Cardiol. 2018;3(10):929-938. doi:10.1001/jamacardio.2018.2541

This study combined secondary analysis of 5 cohorts with murine modeling to assess the association of Bcl2-associated anthanogene 3 (BAG3) genetic variants with outcomes in individuals of African ancestry with dilated cardiomyopathy.

Right Ventricular Function, Right Ventricular–Pulmonary Artery Coupling, and Heart Failure Risk in 4 US CommunitiesThe Atherosclerosis Risk in Communities (ARIC) Study

Abstract Full Text
JAMA Cardiol. 2018;3(10):939-948. doi:10.1001/jamacardio.2018.2454

This study assesses the prevalence of right ventricular dysfunction and its association with heart failure and mortality in a community-based elderly cohort of participants in the Atherosclerosis Risks in the Community (ARIC) Study.

Association Between Aortic Vascular Inflammation and Coronary Artery Plaque Characteristics in Psoriasis

Abstract Full Text
has audio
JAMA Cardiol. 2018;3(10):949-956. doi:10.1001/jamacardio.2018.2769

This study assesses the association between aortic vascular inflammation by fludeoxyglucose F 18 positron emission tomography/computed tomography and coronary artery disease indices by coronary computed tomography angiography.

Association of Genetically Enhanced Lipoprotein Lipase–Mediated Lipolysis and Low-Density Lipoprotein Cholesterol–Lowering Alleles With Risk of Coronary Disease and Type 2 Diabetes

Abstract Full Text
open access
JAMA Cardiol. 2018;3(10):957-966. doi:10.1001/jamacardio.2018.2866

This genetic association study investigates the independent and combined associations of genetically determined differences in lipoprotein lipase–mediated lipolysis and low-density lipoprotein cholesterol metabolism with risk of coronary disease and diabetes.

One-Year Safety and Clinical Outcomes of a Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction in the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (REDUCE LAP-HF I) TrialA Randomized Clinical Trial

Abstract Full Text
has active quiz
JAMA Cardiol. 2018;3(10):968-977. doi:10.1001/jamacardio.2018.2936

This randomized clinical trial evaluates the 1-year safety, patency, and clinical outcomes of a transcatheter interatrial shunt device for patients with heart failure, compared with patients treated with a sham control procedure.

Ross Procedure vs Mechanical Aortic Valve Replacement in AdultsA Systematic Review and Meta-analysis

Abstract Full Text
JAMA Cardiol. 2018;3(10):978-987. doi:10.1001/jamacardio.2018.2946

This systematic review and meta-analysis compares long-term outcomes between the Ross procedure and mechanical aortic valve replacement in adults.

Variation in Survival After Out-of-Hospital Cardiac Arrest Between Emergency Medical Services Agencies

Abstract Full Text
JAMA Cardiol. 2018;3(10):989-999. doi:10.1001/jamacardio.2018.3037

This cohort study at 10 sites in the United States and Canada quantifies variation in patient outcomes across emergency medical service agencies after out-of-hospital cardiac arrest.

Brief Report

Association of Natriuretic Peptides With Cardiovascular Prognosis in Heart Failure With Preserved Ejection FractionSecondary Analysis of the TOPCAT Randomized Clinical Trial

Abstract Full Text
JAMA Cardiol. 2018;3(10):1000-1005. doi:10.1001/jamacardio.2018.2568

This secondary analysis of the TOPCAT randomized clinical trial examines the association of age, race/ethnicity, obesity, renal function, and atrial fibrillation with levels of natriuretic peptides in heart failure with preserved ejection fraction in people in the Americas.

Myocarditis in Duchenne Muscular Dystrophy After Changing Steroids

Abstract Full Text
JAMA Cardiol. 2018;3(10):1006-1010. doi:10.1001/jamacardio.2018.2695

This case report of an 18-year-old man with Duchenne musclar dystrophy highlights the potential adverse effects associated with changing between corticosteroid classes in Duchenne musclar dystrophy cardiomyopathy.

Viewpoint

Assessing the Credibility of Findings From Nonrandomized Studies of Interventions

Abstract Full Text
JAMA Cardiol. 2018;3(10):905-906. doi:10.1001/jamacardio.2018.2267

This Viewpoint presents the Risk Of Bias In Nonrandomized Studies of Interventions tool, which permits researchers to compare nonrandomized studies with hypothetical randomized clinical trials.

From the Heart

Uncertainty

Abstract Full Text
JAMA Cardiol. 2018;3(10):915-916. doi:10.1001/jamacardio.2018.1925

This personal essay recounts the lethal cardiac event of a first-year medical student’s landlord and downstairs neighbor.

Editorial

Viewing the Value of Coronary Artery Calcium Testing From Different Perspectives

Abstract Full Text
JAMA Cardiol. 2018;3(10):908-910. doi:10.1001/jamacardio.2018.2199

Decoding the Right Ventricle in 3 Dimensions

Abstract Full Text
JAMA Cardiol. 2018;3(10):910-911. doi:10.1001/jamacardio.2018.2452

Inflammation, Superadded Inflammation, and Out-of-Proportion Inflammation in Atherosclerosis

Abstract Full Text
has audio
JAMA Cardiol. 2018;3(10):912-914. doi:10.1001/jamacardio.2018.2760
Invited Commentary

Hospice Use and Palliative Care for Patients With Heart FailureNever Say Never in Medicine, but It Is Never Too Early to Start the Conversation

Abstract Full Text
JAMA Cardiol. 2018;3(10):926-928. doi:10.1001/jamacardio.2018.2750

The Ross Operation Comes of Age

Abstract Full Text
JAMA Cardiol. 2018;3(10):988. doi:10.1001/jamacardio.2018.2955
Review

Enrollment of Older Patients, Women, and Racial and Ethnic Minorities in Contemporary Heart Failure Clinical TrialsA Systematic Review

Abstract Full Text
JAMA Cardiol. 2018;3(10):1011-1019. doi:10.1001/jamacardio.2018.2559

This systematic review characterizes the representation of older patients, women, and racial and ethnic minorities in heart failure trials.

JAMA Cardiology Clinical Challenge

71-Year-Old Man With Recurrent Dyspnea Following Transcatheter Aortic Valve Replacement

Abstract Full Text
has multimedia
JAMA Cardiol. 2018;3(10):1020-1021. doi:10.1001/jamacardio.2018.1579

A 71-year-old man presents with subacute progressive dyspnea on exertion after having undergone transcatheter aortic valve replacement 12 months earlier for symptomatic aortic stenosis. What would you do next?

Comment & Response

Left Ventricular Ejection Fraction Cut Point of 50% for Heart Failure With Preserved Ejection Fraction

Abstract Full Text
JAMA Cardiol. 2018;3(10):1023. doi:10.1001/jamacardio.2018.1906

Left Ventricular Ejection Fraction Cut Point of 50% for Heart Failure With Preserved Ejection Fraction—Reply

Abstract Full Text
JAMA Cardiol. 2018;3(10):1023-1024. doi:10.1001/jamacardio.2018.1936

Electrocardiographic Abnormalities in Patients With Hutchinson-Gilford Progeria Syndrome

Abstract Full Text
JAMA Cardiol. 2018;3(10):1024-1025. doi:10.1001/jamacardio.2018.2100

Electrocardiographic Abnormalities in Patients With Hutchinson-Gilford Progeria Syndrome—Reply

Abstract Full Text
JAMA Cardiol. 2018;3(10):1025. doi:10.1001/jamacardio.2018.2103
Editor's Note

Tools for Evaluating and Improving Causal InferenceIntroducing JAMA Cardiology Readers to the Risk of Bias in Nonrandomized Studies of Interventions (ROBINS-I) Tool

Abstract Full Text
JAMA Cardiol. 2018;3(10):907. doi:10.1001/jamacardio.2018.2270

Opportunities and Challenges in Mendelian Randomization Studies to Guide Trial Design

Abstract Full Text
JAMA Cardiol. 2018;3(10):967. doi:10.1001/jamacardio.2018.2863
Correction

Errors in Data Presentation, Funding, and Acknowledgments

Abstract Full Text
free access
JAMA Cardiol. 2018;3(10):1026. doi:10.1001/jamacardio.2018.0038
JAMA Cardiology Masthead

JAMA Cardiology

Abstract Full Text
free access
JAMA Cardiol. 2018;3(10):904. doi:10.1001/jamacardio.2017.3387
×